Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SPRINT BIOSCIENCE AB
No Price
Closing Price XSTO 30.04.2026:
3,11 SEK
30.04.2026 10:59
Current Prices from SPRINT BIOSCIENCE AB
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ STOCKHOLM AB
SPRINT.ST
SEK
30.04.2026 10:59
3,11 SEK
-
Share Float & Liquidity
Free Float5,74 %
Shares Float6,06 M
Shares Outstanding105,52 M
Company Profile for SPRINT BIOSCIENCE AB Share
Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB (publ) was founded in 2009 and is based in Huddinge, Sweden.
